Labyrinthitis. Otogenic intracranial complications (meningitis, meningoencephalitis. arachnoiditis. abscess of the brain and cerebellum. thrombophlebitis of the sigmoid sinus. Explain in detail

Reading File
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Reading File
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
I now have comprehensive material. Let me compile the full, detailed answer.

Labyrinthitis and Otogenic Intracranial Complications


I. LABYRINTHITIS

Labyrinthitis is inflammation of the inner ear (labyrinth) and may be classified as serous or suppurative, based on whether bacteria are actually present within the labyrinth.

A. Serous Labyrinthitis

Pathophysiology Inflammation of the labyrinth in the absence of bacteria or virus within the inner ear itself. Bacterial toxins and inflammatory mediators gain access to the labyrinth through:
  • The round window (RW) — whose membrane permeability increases during inflammation
  • The oval window
  • A labyrinthine fistula
Labyrinthine dysfunction arises from changes in ionic potentials caused by inflammatory mediators, rather than from destruction of neuroepithelium. Because the cochlear and vestibular neuroepithelium are preserved, end-organ function can return to normal once the inflammatory state resolves.
Epidemiology: Most common in the pediatric population due to the high incidence of acute otitis media (AOM).
Signs and Symptoms
  • Typically unilateral
  • Mild to severe sensorineural hearing loss (SNHL)
  • Dizziness (not required for diagnosis)
  • Symptoms are usually reversible over time
Pathogens: Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis
Diagnosis
  • Culture of middle ear effusion
  • Audiogram
  • Vestibular testing when necessary
  • Imaging only if other complications of otitis media (OM) are suspected
  • Histopathology: loss of outer hair cells in the basal turn; significant incidence of endolymphatic hydrops
Treatment
  • Directed at the infectious source (oral antibiotics are typically effective)
  • Steroids (oral and/or intratympanic) may improve hearing outcomes
  • Myringotomy for unresolved middle ear infection
  • Tympanomastoidectomy if cholesteatoma is present

B. Suppurative (Acute) Labyrinthitis

Pathophysiology Bacteria physically invade the labyrinth — always followed promptly by total loss of auditory and vestibular function. Routes of bacterial entry include:
  1. Subarachnoid space (meningitis) — bacteria enter the scala tympani via a patent cochlear aqueduct, or ascend the internal auditory canal (IAC) through perineural/perivascular spaces
  2. Temporal bone (osteomyelitis)
  3. Middle ear (AOM or COM with/without cholesteatoma) — bacterial entry through a labyrinthine fistula or congenital anomaly
The most common association in the modern era is with cholesteatoma. In AOM, the labyrinth is typically invaded through a weakened or dehiscent oval window membrane (as in Mondini deformity, enlarged vestibular aqueducts, or following stapes surgery).
Direct bacterial invasion through a cholesteatomatous lateral semicircular canal fistula is another route — infected granulation tissue beneath the cholesteatoma matrix lies directly on the endosteal membrane and perilymph.
Signs and Symptoms
  • Tinnitus and dizziness rapidly progress to whirling vertigo, pallor, diaphoresis, nausea, and vomiting
  • Brisk nystagmus directed toward the opposite ear
  • Over the first several hours, spontaneous vertigo and nystagmus begin to abate
  • Central nervous system compensation occurs over 2–3 weeks; normal or near-normal balance restored
  • Profound, usually permanent SNHL — 2–20% of patients develop complete deafness (average 10%)
  • In meningitis-related labyrinthitis: bilateral deafness frequent
  • Fever, meningeal signs, evidence of OM or cholesteatoma
  • Cranial neuropathies if spread beyond the otic capsule
Diagnosis
  • Cultures via myringotomy or lumbar puncture
  • CT/MRI: CT demonstrates opacification and erosion of the labyrinth; contrast MRI shows enhancement of middle ear, vestibule, and IAC (see Fig. 141.14)
  • Audiogram
Treatment
  • Appropriate antibiotics for 10 days to eradicate labyrinthine infection and prevent meningeal propagation
  • Treatment of underlying otitis
  • Labyrinthectomy is not necessary in labyrinthitis secondary to AOM
  • When due to cholesteatoma: tympanomastoidectomy

II. OTOGENIC INTRACRANIAL COMPLICATIONS

These are among the most serious consequences of middle ear and mastoid infection. The dramatic reduction in their incidence is attributable to immunization (H. influenzae type B vaccine, PCV13) and effective antibiotic therapy. The most common predisposing pathology is cholesteatoma and chronic suppurative otitis media (CSOM/COM).

1. Meningitis

Pathophysiology & Routes of Spread
  • By far the most common otogenic intracranial complication historically
  • AOM in infants: predominantly hematogenous dissemination
  • COM and mastoiditis: direct extension through eroded bone or via the labyrinth/cochlear aqueduct
  • CSF otorrhea (e.g., from temporal bone fractures, tegmen defects, congenital anomalies of the oval/round window, Mondini dysplasia, enlarged vestibular aqueducts) predisposes to recurrent meningitis
  • Common causative organisms historically: H. influenzae and S. pneumoniae
Clinical Features
  • Headache — generalized, severe
  • Fever — universal, high, sustained
  • Nuchal rigidity — cardinal sign
  • Kernig sign — inability to extend the knee when hip is flexed to 90°
  • Brudzinski sign — passive neck flexion causes involuntary flexion of both thighs and legs
  • Photophobia, general hyperesthesia, nausea
  • Altered level of consciousness (normal to unresponsive)
  • Papilledema on fundoscopy
Diagnosis
  • CT scan first (to rule out brain abscess, cerebritis, or subdural empyema before lumbar puncture)
  • CSF examination: elevated pressure, elevated protein and glucose (compared with serum); organisms appear late
  • MRI with contrast: dural enhancement (Fig. 141.16)
  • Enhanced MRI to rule out additional intracranial complications
Treatment
  • AOM or suppurative labyrinthitis: myringotomy + IV antibiotics; no surgery required
  • COM and mastoiditis: mastoidectomy required to exenterate the infected mastoid (timing determined by neurologic status — perform as soon as patient is stable)
  • Dexamethasone adjunct may reduce adverse outcomes in pneumococcal meningitis
Meningitis is more lethal when caused by COM and mastoiditis than when it is hematogenous in infants. — Cummings Otolaryngology Head and Neck Surgery

2. Meningoencephalitis / Cerebritis

Pathophysiology Cerebritis is the earliest stage of brain parenchymal infection, preceding abscess formation. It may arise from:
  • Direct extension through eroded dura from mastoid disease
  • Retrograde thrombophlebitis of diploic veins
  • Hematogenous spread
Inflammation extends from the meninges into the cerebral cortex, causing focal or diffuse encephalitis. It may progress to frank abscess if untreated.
Clinical Features
  • Headache, fever, altered mental status
  • Focal neurological deficits depending on the area involved
  • Seizures
  • Signs of meningeal irritation may coexist
Diagnosis
  • MRI with contrast: diffuse or focal enhancement without a discrete abscess capsule
  • Differentiated from frank abscess by absence of a ring-enhancing capsule on diffusion-weighted MRI
Treatment
  • Prolonged IV antibiotics
  • Surgical treatment of the underlying ear/mastoid disease
  • Close neurological monitoring for progression to abscess

3. Arachnoiditis

Pathophysiology Inflammation of the arachnoid membrane, typically a sequel to bacterial meningitis or direct extension of infection. Exudate from the subarachnoid space causes arachnoidal adhesions and may obstruct CSF flow, leading to communicating or obstructive hydrocephalus.
Clinical Features
  • Persistent headache
  • Signs of raised intracranial pressure
  • Cranial nerve palsies (CN VI palsy is classic — "Gradenigo's syndrome" in petrous apex involvement)
  • Progressive neurological deterioration if CSF pathways are obstructed
Diagnosis
  • MRI: arachnoidal thickening, enhancement of the leptomeninges, CSF loculations
  • Lumbar puncture (where safe): elevated protein, pleocytosis
Treatment
  • Treatment of underlying infection
  • Corticosteroids to limit fibrosis
  • CSF diversion if hydrocephalus develops

4. Brain Abscess and Cerebellar Abscess

Pathophysiology An intraparenchymal collection of pus, typically developing in two stages: cerebritisencapsulated abscess.
  • Temporal lobe abscess: complication of AOM/COM and mastoiditis — direct extension through the tegmen
  • Cerebellar abscess: complication of posterior fossa mastoid disease — direct extension through the cerebellar plate, or via retrograde thrombophlebitis of emissary veins
  • Hematogenous spread from bacteremia during sinus thrombosis (metastatic abscesses) is another mechanism
  • Epidural abscess frequently coexists and is often found at surgery
Microbiology: Same organisms as the underlying otitis — Streptococcus species, anaerobes, gram-negative rods, mixed flora
Clinical Features — Temporal Lobe Abscess
  • Headache is the predominant symptom
  • Aphasia (left-sided lesions)
  • Progressive contralateral hemiparesis
  • Paralysis of conjugate gaze to the contralateral side; deviation of eyes toward the lesion
  • Jacksonian seizures
  • Papilledema
Clinical Features — Cerebellar Abscess
  • Localizing signs often absent
  • Marked nuchal rigidity and papilledema always present
  • Ataxia, dysmetria (when localizing signs do appear)
  • Signs of raised ICP
Diagnosis
  • CT with contrast: ring-enhancing lesion; surrounding low-density edema
  • MRI (preferred): axial T2 shows abscess cavity and surrounding edema; contrast T1 shows enhancing capsule (Fig. 141.17)
  • Diffusion-weighted MRI: restricted diffusion within the abscess cavity (distinguishes from necrotic tumor)
  • Lumbar puncture is contraindicated when abscess is present (risk of transtentorial herniation)
Treatment
  • Surgical drainage of the abscess takes priority over mastoid surgery
  • Immediately followed by mastoidectomy (or can be performed simultaneously if patient stable)
  • IV antibiotics for 6–8 weeks
  • Serial imaging to confirm resolution

5. Subdural Empyema (Subdural Abscess)

Pathophysiology A collection of pus in the subdural space, typically from direct spread of infection after erosion of the dura by cholesteatoma or granulation tissue. Infection can also spread via retrograde thrombophlebitis of cortical bridging veins.
Clinical Features Evolves rapidly — the entire clinical picture may develop in hours to 10 days:
  • High fever, severe headache, signs of meningeal irritation (early stage — may resemble meningitis)
  • Then: focal neurological deterioration — aphasia, contralateral hemiparesis, gaze deviation, Jacksonian seizures, papilledema
  • Posterior fossa empyema: marked neck stiffness, papilledema; localizing signs often absent
Diagnosis
  • CT with contrast: crescent-shaped, low-density collection displacing the brain from the inner table; peripheral cortical enhancement
  • CT may appear normal early — if clinical suspicion is high and focal signs are absent, MRI should be obtained
  • LP is dangerous and contraindicated due to risk of coning (transtentorial herniation)
Treatment
  • Emergency neurosurgical drainage (craniotomy/burr holes)
  • Appropriate antibiotic therapy
  • Prognosis related to level of consciousness at time of surgery — early surgery is critical

6. Epidural Abscess

Pathophysiology Bone erosion by cholesteatoma, granulation tissue, or coalescent mastoiditis allows formation of a pus collection between the temporal bone and the dura. The dura thickens in response — pachymeningitis. Often asymptomatic alone, but frequently associated with lateral sinus thrombophlebitis, meningitis, and brain abscess.
Clinical Features
  • Deep mastoid pain (most common symptom)
  • Often discovered incidentally at mastoid surgery (no specific signs)
  • Large collections detectable on imaging
Diagnosis
  • CT/MRI with contrast: fluid-filled cavity between temporal bone and enhanced dura
Treatment
  • Mastoidectomy with complete exenteration of diseased air cells
  • Granulation tissue scraped from abscess cavity with blunt instruments
  • Antibiotic therapy

7. Thrombophlebitis of the Sigmoid (Lateral) Sinus

Pathophysiology The lateral sinus (sigmoid and/or transverse sinus) is intimately related to the posterior mastoid wall. Thrombosis develops through:
  1. Direct extension: Mastoid bone erosion (cholesteatoma, granulation tissue, coalescence) leads to a perisinus abscess, which exerts pressure on the dural outer wall → necrosis extending to the intima → fibrin, blood cells, and platelets attracted → mural thrombus forms, becomes infected, enlarges, and occludes blood flow
  2. Osteothrombophlebitis: During AOM/mastoiditis, with intact bony sinus plate — infection spreads via emissary veins from mastoid air cells to the transverse sinus
Propagation: Fresh infected thrombus can extend to the transverse sinus, torcular herophili, superior sagittal sinus, internal jugular vein, and cavernous sinus. The infected clot showers the bloodstream with bacteria → septicemia → metastatic abscesses (most commonly lungs).
Clinical Features
  • Headache and earache — most frequent symptoms
  • Fever (often spiking, "picket-fence" pattern with septic emboli)
  • Sixth nerve palsy (Gradenigo's syndrome if petrous apex involved)
  • Neck pain — from internal jugular vein thrombosis
  • Signs of sudden intracranial hypertension: sudden severe headache worsening, papilledema
  • Progressive obtundation — heralds cerebral edema (especially if superior sagittal sinus or cavernous sinus involved); carries very high mortality
  • Torticollis (neck held toward the side of the lesion with sternocleidomastoid spasm)
Diagnosis
  • CT with contrast: "delta sign" — absence of contrast within the sigmoid sinus lumen with enhancement of the sinus wall
  • MRI: absent flow void within the sinus; sensitive for detecting associated abscess, subdural empyema, or cerebritis
  • MR venography or CT venography: confirms occlusion (Fig. 141.19)
  • Cerebral angiography (venous phase): used if MRI/CT is indeterminate
Treatment
  • Mastoidectomy is mandatory to treat underlying disease
  • Brain abscess (if coexistent) is drained first
  • Clot management remains controversial:
    • Anticoagulation (LMWH/unfractionated heparin): recommended when thrombus extends to transverse/cavernous sinus or septic emboli are present
    • Jugular vein ligation in the neck: considered if thrombus extends into the neck or septic emboli are present
    • Clot evacuation: considered if sinus wall appears disrupted during surgery; linear incision into sinus wall, evacuation of pus and infected clots
    • IV thrombolytics: not routinely used in infected vessel walls
  • Antibiotics continued for 6 weeks or until radiographic resolution of thrombosis

Summary Table: Otogenic Intracranial Complications

ComplicationKey FeaturesDiagnostic SignTreatment
MeningitisHeadache, nuchal rigidity, Kernig/Brudzinski signsCSF pleocytosis; dural enhancement (MRI)Antibiotics ± mastoidectomy
MeningoencephalitisFever, focal deficits, seizuresMRI: focal/diffuse enhancement (no capsule)IV antibiotics, treat source
ArachnoiditisPersistent headache, CN palsies, hydrocephalusMRI: leptomeningeal thickeningAntibiotics, steroids, CSF diversion
Temporal lobe abscessAphasia, contralateral hemiparesis, seizuresMRI: ring-enhancing lesion + edemaSurgical drainage + mastoidectomy + antibiotics
Cerebellar abscessNuchal rigidity, papilledema; minimal localizing signsMRI: posterior fossa ring-enhancing lesionSurgical drainage + mastoidectomy
Subdural empyemaCrescent-shaped pus; rapid neurological declineCT: crescent-shaped hypodense subdural collectionEmergency neurosurgical drainage
Epidural abscessDeep mastoid pain; often found incidentallyCT/MRI: extradural fluid collectionMastoidectomy + débridement
Sigmoid sinus thrombosisHeadache, earache, spiking fever, neck pain"Delta sign" on CT; absent flow void on MRIMastoidectomy ± anticoagulation ± clot evacuation

Sources: Cummings Otolaryngology Head and Neck Surgery, Chapter 141 (pp. 2716–2722); K.J. Lee's Essential Otolaryngology (pp. 460–462); Harrison's Principles of Internal Medicine 22E, Chapter 145 (pp. 2491–2517)
This is a shared conversation. Sign in to Orris to start your own chat.